Sandbox:Ifeoma Anaya: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
{| class="wikitable"
|+
!Type of Rash/Lesion
!Description
|-
|Macule
|flat, circumscribed, usually <1cm in diameter
|-
|Papule
|raised/elevated lesion <1cm in diameter
|-
|Maculopapular
|combination of both macules and papulus
|-
|Nodule
|papule in deeper dermis or subcutaneous tissue
|-
|Pustule
|circumscribed raised lesion containing purulent material
|-
|Vesicle
|circumscribed elevated skin lesion usually <1cm containing fluid
|-
|Bulla
|Bigger vesicle (>1cm and containing fluid)
|-
|Purpura
|non-blanching papules or macules due to extravasation of RBCs
|}
{{SK}} Exanthema subitum; sixth disease; roseola infantilis; baby measles; three-day fever; rose rash of infants
{{SK}} Exanthema subitum; sixth disease; roseola infantilis; baby measles; three-day fever; rose rash of infants
==Roseola Infantum==
==Roseola Infantum==
==Overview==
==Overview==
==Historical Perspective==
==Historical Perspective==
Previously known as "Roseola infantilis", the oldest known description of the disease dates as far back as 100 years ago by John Zahorsky, M.D in his publication in 1913 <ref name="Zahorsky1913">{{cite journal|last1=Zahorsky|first1=John|title=ROSEOLA INFANTUM|journal=JAMA: The Journal of the American Medical Association|volume=61|issue=16|year=1913|pages=1446|issn=0098-7484|doi=10.1001/jama.1913.04350170028008}}</ref> <ref name="Altschuler2000">{{cite journal|last1=Altschuler|first1=Eric Lewin|title=OLDEST DESCRIPTION OF ROSEOLA AND IMPLICATIONS FOR THE ANTIQUITY OF HUMAN HERPESVIRUS 6|journal=The Pediatric Infectious Disease Journal|volume=19|issue=9|year=2000|pages=903|issn=0891-3668|doi=10.1097/00006454-200009000-00025}}</ref>. Described as a symptom-complex of febrille erythema occuring in infants and not to be categorized alongside the erythema group of skin diseases. However, no clear-cut description was given to differentiate it from other pediatric skin eruptions <ref name="Zahorsky1913">{{cite journal|last1=Zahorsky|first1=John|title=ROSEOLA INFANTUM|journal=JAMA: The Journal of the American Medical Association|volume=61|issue=16|year=1913|pages=1446|issn=0098-7484|doi=10.1001/jama.1913.04350170028008}}</ref>. While the disease has been recognized for almost a century, Human Herpes Virus type 6 (HHV-6) was discovered in 1986 <ref name="pmid15653828">{{cite journal| author=De Bolle L, Naesens L, De Clercq E| title=Update on human herpesvirus 6 biology, clinical features, and therapy. | journal=Clin Microbiol Rev | year= 2005 | volume= 18 | issue= 1 | pages= 217-45 | pmid=15653828 | doi=10.1128/CMR.18.1.217-245.2005 | pmc=544175 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15653828  }} </ref>.
Previously known as "Roseola infantilis", the oldest known description of the disease dates as far back as 100 years ago by John Zahorsky, M.D in his publication in 1913 . Described as a symptom-complex of febrille erythema occuring in infants and not to be categorized alongside the erythema group of skin diseases. However, no clear-cut description was given to differentiate it from other pediatric skin eruptions <ref name="Zahorsky1913">{{cite journal|last1=Zahorsky|first1=John|title=ROSEOLA INFANTUM|journal=JAMA: The Journal of the American Medical Association|volume=61|issue=16|year=1913|pages=1446|issn=0098-7484|doi=10.1001/jama.1913.04350170028008}}</ref>. While the disease has been recognized for almost a century, Human Herpes Virus type 6 (HHV-6) was discovered in 1986 .
==Pathophysiology==
==Pathophysiology==
Mode of transmission is still not fully understood however it has been speculated that it is primarily via saliva and commonest form of transmission is from mother to child <ref name="pmid28846307">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume= | issue=  | pages=  | pmid=28846307 | doi= | pmc= | url= }} </ref> <ref name="pmid9227865">{{cite journal| author=Braun DK, Dominguez G, Pellett PE| title=Human herpesvirus 6. | journal=Clin Microbiol Rev | year= 1997 | volume= 10 | issue= 3 | pages= 521-67 | pmid=9227865 | doi=10.1128/CMR.10.3.521-567.1997 | pmc=172933 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9227865  }} </ref>. Viral replication occur mostly in CD4+ T cells and incubation period is between 9-10 days <ref name="pmid28846307">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=28846307 | doi= | pmc= | url= }} </ref>.  
Mode of transmission is still not fully understood however it has been speculated that it is primarily via saliva and commonest form of transmission is from mother to child  . Viral replication occur mostly in CD4+ T cells and incubation period is between 9-10 days <ref name="pmid28846307">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=28846307 | doi= | pmc= | url= }} </ref>.  
High levels of Metalloproteinase 9 and Tissue Inhibitor of Metalloproteinase 1 has been shown to disrupt the blood-brain barrier and thus, the cause of the febrille seizures observed in some infants infected with the virus <ref name="pmid25156011">{{cite journal| author=Kittaka S, Hasegawa S, Ito Y, Ohbuchi N, Suzuki E, Kawano S | display-authors=etal| title=Serum levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in human herpesvirus-6-infected infants with or without febrile seizures. | journal=J Infect Chemother | year= 2014 | volume= 20 | issue= 11 | pages= 716-21 | pmid=25156011 | doi=10.1016/j.jiac.2014.07.017 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25156011  }} </ref>.  More severe disease pathology can be seen in the immunocompromised because it remains latent in the lymphocytes and monocytes after primary infection <ref name="pmid19319952">{{cite journal| author=Bates M, Monze M, Bima H, Kapambwe M, Clark D, Kasolo FC | display-authors=etal| title=Predominant human herpesvirus 6 variant A infant infections in an HIV-1 endemic region of Sub-Saharan Africa. | journal=J Med Virol | year= 2009 | volume= 81 | issue= 5 | pages= 779-89 | pmid=19319952 | doi=10.1002/jmv.21455 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19319952  }} </ref> <ref name="pmid11486597">{{cite journal| author=Yoshikawa T| title=Human herpesvirus 6 infection in transplantation. | journal=Nagoya J Med Sci | year= 2001 | volume= 64 | issue= 1-2 | pages= 11-8 | pmid=11486597 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11486597  }} </ref>.   
High levels of Metalloproteinase 9 and Tissue Inhibitor of Metalloproteinase 1 has been shown to disrupt the blood-brain barrier and thus, the cause of the febrille seizures observed in some infants infected with the virus .  More severe disease pathology can be seen in the immunocompromised because it remains latent in the lymphocytes and monocytes after primary infection   .   
==Causes==
==Causes==
Disease is caused by HHV-6 and less commonly by HHV-7 which are members of the '''''Herpesviridae''''' family <ref name="pmid28846307">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=28846307 | doi= | pmc= | url= }} </ref>. HHV-6 has a linear, double-stranded DNA genome <ref name="pmid28846307">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=28846307 | doi= | pmc= | url= }} </ref>. The HHV-6 has its primary variant, HHV-6B which is the associated with Roseola infantum while the other variant, HHV-6A has not been associated with any disease(s) <ref name="pmid28846307">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=28846307 | doi= | pmc= | url= }} </ref>.
Disease is caused by HHV-6 and less commonly by HHV-7 which are members of the '''''Herpesviridae''''' family <ref name="pmid28846307">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=28846307 | doi= | pmc= | url= }} </ref>. HHV-6 has a linear, double-stranded DNA genome <ref name="pmid28846307">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=28846307 | doi= | pmc= | url= }} </ref>. The HHV-6 has its primary variant, HHV-6B which is the associated with Roseola infantum while the other variant, HHV-6A has not been associated with any disease(s) <ref name="pmid28846307">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=28846307 | doi= | pmc= | url= }} </ref>.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
Children are the most commonly infected. Newborns have passive antibodies to HHV-6 passed on to them from their mother which wanes by 4-6 months <ref name="pmid25462439">{{cite journal| author=Tesini BL, Epstein LG, Caserta MT| title=Clinical impact of primary infection with roseoloviruses. | journal=Curr Opin Virol | year= 2014 | volume= 9 | issue=  | pages= 91-6 | pmid=25462439 | doi=10.1016/j.coviro.2014.09.013 | pmc=4267952 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25462439  }} </ref>. By 12 months of age, incidence of the disease is about 40%, this increases to 77% by 24 months <ref name="pmid25462439">{{cite journal| author=Tesini BL, Epstein LG, Caserta MT| title=Clinical impact of primary infection with roseoloviruses. | journal=Curr Opin Virol | year= 2014 | volume= 9 | issue=  | pages= 91-6 | pmid=25462439 | doi=10.1016/j.coviro.2014.09.013 | pmc=4267952 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25462439  }} </ref>. Primary infection peaks between 9-21 months of age <ref name="pmid25462439">{{cite journal| author=Tesini BL, Epstein LG, Caserta MT| title=Clinical impact of primary infection with roseoloviruses. | journal=Curr Opin Virol | year= 2014 | volume= 9 | issue=  | pages= 91-6 | pmid=25462439 | doi=10.1016/j.coviro.2014.09.013 | pmc=4267952 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25462439  }} </ref>.
Children are the most commonly infected. Newborns have passive antibodies to HHV-6 passed on to them from their mother which wanes by 4-6 months . By 12 months of age, incidence of the disease is about 40%, this increases to 77% by 24 months <ref name="pmid25462439">{{cite journal| author=Tesini BL, Epstein LG, Caserta MT| title=Clinical impact of primary infection with roseoloviruses. | journal=Curr Opin Virol | year= 2014 | volume= 9 | issue=  | pages= 91-6 | pmid=25462439 | doi=10.1016/j.coviro.2014.09.013 | pmc=4267952 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25462439  }} </ref>. Primary infection peaks between 9-21 months of age <ref name="pmid25462439">{{cite journal| author=Tesini BL, Epstein LG, Caserta MT| title=Clinical impact of primary infection with roseoloviruses. | journal=Curr Opin Virol | year= 2014 | volume= 9 | issue=  | pages= 91-6 | pmid=25462439 | doi=10.1016/j.coviro.2014.09.013 | pmc=4267952 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25462439  }} </ref>.
==Natural History, Complications and Prognosis==
==Natural History, Complications and Prognosis==
Classical finding of Roseola infantum is very high fever which can be higher than 39°C <ref name="pmid28846307">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=28846307 | doi= | pmc= | url= }} </ref>. This fever lasts for 3-5 days and can be accompanied by other symptoms like malaise, conjuctivitis, inflammed tympanum, anorexia, irritability, lymphadenopathy, cough, etc <ref name="pmid28846307">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=28846307 | doi= | pmc= | url= }} </ref>. On sudden disappearance of the fever (3-5 days later), small, rose-pink, non-pruritic, blanching, maculopapular rashes appear first on the trunk and then spreads to the neck, face and extremities <ref name="pmid28846307">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=28846307 | doi= | pmc= | url= }} </ref>. This usually lasts 1-2 days and ends the infection period <ref name="pmid28846307">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=28846307 | doi= | pmc= | url= }} </ref>.
Classical finding of Roseola infantum is very high fever which can be higher than 39°C <ref name="pmid28846307">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=28846307 | doi= | pmc= | url= }} </ref>. This fever lasts for 3-5 days and can be accompanied by other symptoms like malaise, conjuctivitis, inflammed tympanum, anorexia, irritability, lymphadenopathy, cough, etc <ref name="pmid28846307">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=28846307 | doi= | pmc= | url= }} </ref>. On sudden disappearance of the fever (3-5 days later), small, rose-pink, non-pruritic, blanching, maculopapular rashes appear first on the trunk and then spreads to the neck, face and extremities <ref name="pmid28846307">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=28846307 | doi= | pmc= | url= }} </ref>. This usually lasts 1-2 days and ends the infection period <ref name="pmid28846307">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=28846307 | doi= | pmc= | url= }} </ref>.
Line 64: Line 93:
|}
|}
Practice here
Practice here




Line 105: Line 133:
|-
|-
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |
'''Bowen's disease Microchapters'''
'''Bowen's disease Microchapters'''
|- bgcolor="LightGrey"
|- bgcolor="LightGrey"
Line 172: Line 199:
|-
|-
|}
|}




Line 184: Line 210:


==References==
==References==
<references />

Revision as of 06:56, 9 September 2020

Type of Rash/Lesion Description
Macule flat, circumscribed, usually <1cm in diameter
Papule raised/elevated lesion <1cm in diameter
Maculopapular combination of both macules and papulus
Nodule papule in deeper dermis or subcutaneous tissue
Pustule circumscribed raised lesion containing purulent material
Vesicle circumscribed elevated skin lesion usually <1cm containing fluid
Bulla Bigger vesicle (>1cm and containing fluid)
Purpura non-blanching papules or macules due to extravasation of RBCs

Synonyms and keywords: Exanthema subitum; sixth disease; roseola infantilis; baby measles; three-day fever; rose rash of infants

Roseola Infantum

Overview

Historical Perspective

Previously known as "Roseola infantilis", the oldest known description of the disease dates as far back as 100 years ago by John Zahorsky, M.D in his publication in 1913 . Described as a symptom-complex of febrille erythema occuring in infants and not to be categorized alongside the erythema group of skin diseases. However, no clear-cut description was given to differentiate it from other pediatric skin eruptions [1]. While the disease has been recognized for almost a century, Human Herpes Virus type 6 (HHV-6) was discovered in 1986 .

Pathophysiology

Mode of transmission is still not fully understood however it has been speculated that it is primarily via saliva and commonest form of transmission is from mother to child . Viral replication occur mostly in CD4+ T cells and incubation period is between 9-10 days [2]. High levels of Metalloproteinase 9 and Tissue Inhibitor of Metalloproteinase 1 has been shown to disrupt the blood-brain barrier and thus, the cause of the febrille seizures observed in some infants infected with the virus . More severe disease pathology can be seen in the immunocompromised because it remains latent in the lymphocytes and monocytes after primary infection .

Causes

Disease is caused by HHV-6 and less commonly by HHV-7 which are members of the Herpesviridae family [2]. HHV-6 has a linear, double-stranded DNA genome [2]. The HHV-6 has its primary variant, HHV-6B which is the associated with Roseola infantum while the other variant, HHV-6A has not been associated with any disease(s) [2].

Epidemiology and Demographics

Children are the most commonly infected. Newborns have passive antibodies to HHV-6 passed on to them from their mother which wanes by 4-6 months . By 12 months of age, incidence of the disease is about 40%, this increases to 77% by 24 months [3]. Primary infection peaks between 9-21 months of age [3].

Natural History, Complications and Prognosis

Classical finding of Roseola infantum is very high fever which can be higher than 39°C [2]. This fever lasts for 3-5 days and can be accompanied by other symptoms like malaise, conjuctivitis, inflammed tympanum, anorexia, irritability, lymphadenopathy, cough, etc [2]. On sudden disappearance of the fever (3-5 days later), small, rose-pink, non-pruritic, blanching, maculopapular rashes appear first on the trunk and then spreads to the neck, face and extremities [2]. This usually lasts 1-2 days and ends the infection period [2].

Complications seen during primary infection include febrille seizures, rhabdomyolysis, myocarditis, Guillain-Barre Syndrome [2]. Limbic encephalitis seen in immunocompromised individuals post stem cell transplantation is an established long-term complication as a result of reactivation of HHV-6B virus [3].

Roseola infantum is a self limiting infection with very good prognosis and few complications [2].

Diagnosis

This is basically clinical. A well taken history and physical exam gives away the diagnosis of Roseola infantum and differentiates it from other viral exanthems.

Treatment

Usually supportive with antipyretics for fever and general discomfort, continued fluid intake to replace insensible losses from high temperatures, and rest. There is currently no vaccine for HHV-6 and no antiviral treatment for primary infection [2].

Prevention

Hand washing is encouraged to prevent spread [2].

Differentiating Roseola Infantum from other Diseases

classification
SCC
BCC
Melanoma

Practice here


Mitosis in neuroendocrine tumor. Source: Wikimedia commons
Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders
Criteria Symptomatic WM Asymptomatic WM IgM-Related Disorders MGUS
IgM monoclonal protein + + + +
Bone marrow infiltration + + - -
Symptoms attributable to IgM + - + -
Symptoms attributable to tumor infiltration + - - -

Bowen's disease Microchapters

Overview

Historical Perspective

Pathophysiology

Causes

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

Treatment

Prevention

Differentiating Bowen's disease from other Diseases






References

  1. Zahorsky, John (1913). "ROSEOLA INFANTUM". JAMA: The Journal of the American Medical Association. 61 (16): 1446. doi:10.1001/jama.1913.04350170028008. ISSN 0098-7484.
  2. 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 "StatPearls". 2020. PMID 28846307.
  3. 3.0 3.1 3.2 Tesini BL, Epstein LG, Caserta MT (2014). "Clinical impact of primary infection with roseoloviruses". Curr Opin Virol. 9: 91–6. doi:10.1016/j.coviro.2014.09.013. PMC 4267952. PMID 25462439.